ACHCAcadia Healthcare Company, Inc.

$30.58

Price

$30.58+68%1Y
1M-10.0%1Y+68%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average
8/10
Value75
Quality45
Momentum63
Growth52
Strongest Value, weakest Quality · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

Our business strategy is to become the indispensable behavioral healthcare provider for the high-acuity and complex needs patient population. We are committed to providing the communities we serve with high-quality, cost-effective behavioral healthcare services, while growing our business, increasing profitability and creating long-term value for our stockholders. This strategy includes five growth pathways: expansions of existing facilities, joint venture partnerships, de novo facilities, acquisitions and expansion across our continuum of care.

In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR

P/E (TTM)-
Market Cap$2.29B
1Y Return+68%
5Y Return-50%

Business segments

Q1 2026 · $828.8M

The company’s own SEC segment disclosure.

  • Acute Inpatient Psychiatric Facilities$470.7M57%
  • Comprehensive Treatment Centers$140.4M17%
  • Specialty Treatment Facilities$128.1M15%
  • Residential Treatment Centers$89.6M11%

Acadia Healthcare Company, Inc. (ACHC) reported revenue of $829M in Q1 2026 (quarter ended March 31, 2026), up 7.6% from the same quarter a year earlier. That came with net income of $4.1M (0.5% of revenue). For the full year FY2025, revenue was $3.31B (+5.0% year on year) and net income −$1.10B. Its largest product in 2026-Q1 was Acute Inpatient Psychiatric Facilities at $471M, 57% of the disclosed total, just ahead of Comprehensive Treatment Centers at 17%.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.